You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Spain

Sep 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Spain with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Spain, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Spain for free:

The Consumer Health in Spain market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Spain?
  • What are the major brands in Spain?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Spain in deep economic crisis

Spain has been hit hard by the global financial crisis, with 2008 representing a turning point for the previously dynamic Spanish economy. In 2009 and 2010, GDP contracted sharply, while unemployment rose substantially. This translated into a substantial drop in consumption and a higher level of savings. Spaniards are trying to find ways to save money, for example by switching from OTC references to reimbursed substitutes. While health remains a key concern that is not viewed as a non-essential expenditure, the economic environment has negatively affected consumer health sales, which slowed down significantly in current value terms in 2009 and 2010 compared with earlier years of the review period.

New legislative framework shapes sales

In order to reduce the excessive public deficit, the government passed a new law on reference prices in 2010, which reduced the average unit price of medicines in Spain. This has particularly affected those categories where the importance of semi-ethical products is higher. In the same year, a new and more comprehensive ban on smoking was passed by the Spanish government. With this new ban, smoking is not allowed in any public places, or any place where children could be exposed to tobacco, such as parks or recreation areas. The law will not come into force before January 2011; however, some Spanish regions, such as the Basque Country, have already began to apply similar laws, which helped to push sales of NRT smoking cessation aids.

Fragmented competitive environment

The Spanish consumer health market concentrates over 100 companies, with a very high level of fragmentation. However, since the acquisition of Spanish laboratory Abelló in 2008, and of the consumer division of Pfizer, McNeil Iberica SLU, the Spanish subsidiary of Johnson & Johnson, has led sales of consumer health in Spain. In second and third places in 2010 were Bayer Hispania SA and Almirall Prodesfarma SA.

Grocery retailers are the winners

The poor economic situation has resulted in a drop in Spanish average disposable incomes, and hence price has become a key variable in consumer purchasing decisions. As a result, those outlets offering better value for money have been the winners in taking a higher proportion of sales, in particular “other” grocery retailers. Direct sales have also benefited from the crisis, as a number of Spaniards have become distributors for these companies in order to earn some extra money, which has benefited their sales. However, distribution of consumer health products remains highly regulated in Spain, with chemists/pharmacies continuing to dominate the market.

Gloomy outlook

According to the IMF, OECD and the European Commission, Spain is set to be one of the countries taking a longer time to emerge from the economic crisis, with recovery taking place in 2011 at the earliest, despite the positive although minimal growth rates recorded in 2010. A key factor hampering the recovery in Spain will be the high rate of unemployment, which is already above 20% of the economically active population. This will bring an environment of uncertainty to Spanish consumers, affecting sales of consumer health products, which are predicted to see a flat performance over the forecast period.

Table of Contents

Table of Contents

Consumer Health in Spain - Industry Overview

EXECUTIVE SUMMARY

Spain in deep economic crisis

New legislative framework shapes sales

Fragmented competitive environment

Grocery retailers are the winners

Gloomy outlook

KEY TRENDS AND DEVELOPMENTS

Spanish economy

Legislation shaping sales

Spanish demographics

Spain not spared the obesity issue

Cosmetics and consumer health line blurring

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Consumer Health Registration and Classification

Advertising

Packaging and Labelling

Distribution

De-listing or de-reimbursement

Vitamins and Dietary Supplements Registration and Classification

Retail Distribution

Self-medication/Self-care and Preventative Medicine

Alternative Therapy

Homoeopathic Medicines

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Spain - Company Profiles

Almirall Prodesfarma SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Almirall Prodesfarma SA: Competitive Position 2010

Bayer Hispania SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Bayer Hispania SA: Competitive Position 2010

Bicentury SL in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Bicentury SL: Competitive Position 2010

Boehringer Ingelheim España SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Boehringer Ingelheim España SA: Competitive Position 2010

Esteve SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Esteve SA: Competitive Position 2010

Laboratorios Viñas SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 18 Laboratorios Viñas SA: Competitive Position 2010

McNeil Iberica SLU in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 20 McNeil Iberica SLU: Competitive Position 2010

Novartis Farmaceutica SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 23 Novartis Farmaceutica SA: Competitive Position 2010

Rovi SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Uriach-Aquilea OTC SL in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 28 Uriach-Aquilea OTC SL: Competitive Position 2010

Adult Mouth Care in Spain - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care sales dropped by almost 2% in 2010. OTC adult mouth care has the advantage of being almost free from competition from prescription-only products, and hence the substitution of OTC by reimbursed references is not as prevalent as in other consumer health categories. However, adult mouth care does experience competition from cosmetic products. This is especially important in the case of mouthwashes, with cosmetic products such as Listerine being used instead of adult mouth care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Company shares were steady over the review period, in an environment that sees little dynamism. The only change came from the acquisition by Johnson & Johnson of Pfizer Healthcare, which resulted in Johnson & Johnson’s subsidiary McNeil leading sales through the brand Oraldine, with a 64% value share.

PROSPECTS

  • Sales of adult mouth care products are predicted to drop by 4% in constant value terms over the forecast period. A recovery in sales is expected from 2014 onwards, as the Spanish economy recovers. However, sales will still suffer from significant competition from oral hygiene products that are not included in consumer healthcare.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Spain - Category Analysis

HEADLINES

TRENDS

  • The Spanish economic crisis and its consequences in terms of unemployment and the public deficit contributed to the poor performance of analgesics in 2010. The unemployment rate reached 20% in 2010, and is expected to rise further. As a result, the average Spanish disposable income is dropping, and Spaniards are consequently shifting from OTC products to cheaper reimbursed substitutes. As the economy struggles, Spaniards’ shopping habits are changing, with price being the key variable taken into account when making purchase decisions. In the Spanish market, the same active ingredient can be found both reimbursed and as OTC, and as pessimism characterises Spanish economic expectations and consumers decide to save instead of spend, the number of prescriptions is growing, to the detriment of OTC sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • No major changes took place in the Spanish analgesics category in 2010. Sales were still led by Bayer, although the company lost some ground over the previous year. Bayer has been active in the promotion and advertising of its latest launches, especially Aspitopic and the new format of Aspirin; however, brands from other companies, such as Reckitt, are gaining popularity to the detriment of Bayer.

PROSPECTS

  • The strong pressure to reduce Spain’s public deficit will continue be met by new restrictive measures which will clearly dampen OTC sales. On the one hand, following the VAT increase in 2010, new tax increases are expected in the early years of the forecast period. As a result, Spanish disposable incomes will drop and Spaniards will continue to substitute OTC products with reimbursed references. On the other hand, with the new reference price law having been passed in 2010, new cuts in prices are expected in order to reduce public health expenditure. This policy will especially damage those categories where semi-ethicals are important, such as digestive remedies and analgesics. Sales of analgesics are set to drop by 10% in constant value terms over the 2010-2015 period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Spain - Category Analysis

HEADLINES

TRENDS

  • A study carried out in 2010 by one of the leading Spanish hospitals in terms of research, Hospital La Paz, revealed that since the beginning of the Spanish economic crisis, the number of Spaniards suffering from anxiety-related problems has increased by 50%. Economic performance-related problems, such as being unemployed and being unable to deal with debts, are the main reasons for the rise in stress and anxiety. This is supporting sales of calming and sleeping products in Spain, which grew by 4% in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • In terms of the competitive landscape, Esteve ranked first in 2010, with a value share of 54%, achieved through its brand Dormidina. Dormidina gained ground over the previous year, as it benefited from the growing popularity of standard references at the expense of herbal/traditional offerings.

PROSPECTS

  • Sales of calming and sleeping products are expected to rise by 19% in constant value terms over the forecast period. Sales will benefit from the growing number of Spaniards suffering nervous problems, as economic problems continue to affect Spanish families, and from the restrictive expenditure policies the government is set to follow over the forecast period in order to satisfy other priorities rather than expenditure on medicines.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Spain - Category Analysis

HEADLINES

TRENDS

  • Sales of cough and cold products depend to some extent on the virulence of flu outbreaks. The arrival of the H1N1 flu during summer 2009 resulted in a big scare amongst the Spanish and international authorities, as the mortality associated with the virus was not known. The outbreak was not as serious as initially feared, and in 2010 the new virus was included in the flu vaccination.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are over 30 companies active in cough, cold and allergy (hay fever) remedies, making it a highly fragmented category. In 2010, the Johnson & Johnson subsidiary McNeil remained the leading company, thanks to the leading position of its combination product Frenadol.

PROSPECTS

  • The slower than hoped for recovery of the Spanish economy, held back by the substantial public deficit, is resulting in a high level of unemployment – over 20% in 2010 – and in the government increasing taxes. Both factors are resulting in a drop in the average Spanish disposable income, which will continue over the forecast period. As a consequence, Spaniards will think carefully how they spend their money and will try to switch from OTC references to reimbursed ones. As a result, sales of cough, cold and allergy (hay fever) remedies are expected to drop by a total of 5% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Spain - Category Analysis

HEADLINES

TRENDS

  • According to industry sources, in Spain more than 13 million people suffer from reflux-related problems, and this number is growing due to the increasing levels of stress the economic crisis is provoking amongst Spaniards. This fact shaped the performance of digestive remedies – both OTC and prescription-bound – in 2010. Digestive remedies, as in other OTC categories, have suffered from the economic crisis, as the decline in the average disposable income has resulted in a growing number of consumers switching to reimbursed references, when available, in order to save money. Overall, these factors balanced each other out, with sales remaining stable in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Digestive remedies is one of Spanish consumer health categories where sales are highly concentrated, with the four leading companies accounting for 67% of total value sales in 2010. In ranking terms, no major changes took place, with Almirall remaining the leader.

PROSPECTS

  • Digestive remedies, where the importance of semi-ethical offerings is high compared with other consumer health categories, is set to be particularly badly affected by the gloomy economic outlook. The economic crisis has put more pressure on the government’s budget, and in June 2010 another price reference law was passed in order to contain health expenditure. New initiatives and legislation to promote OTC products will be introduced by the Spanish government in order to save public money. Sales of digestive remedies are set to decline by 2% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Spain - Category Analysis

HEADLINES

TRENDS

  • According to a study carried out by Laboratorios Esteve, an industry player, in 2010, one out of three Spaniards suffered from ear problems which could have been prevented if proper ear hygiene had been used. This shows that Spaniards lack knowledge of the ear and of ear care. This lack of a culture of ear care is reflected in low sales, which dropped by 1% to €1.8 million in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • The end of the review period saw increasing interest among Spaniards in ear care products, due to launches of new offerings, such as Audimer and Audispray. Both are sold through parapharmacies and their main ingredient is sea water. Both have been heavily advertised.

PROSPECTS

  • Sales of ear care products are expected to decline by 4% in constant value terms over the forecast period. The poor economic environment and the high unemployment rate will result in Spaniards prioritising where to spend their money, and OTC references will suffer from substitution by cheaper reimbursed medicines. Nevertheless, if further de-listing of products by the Spanish government takes place, in order to reduce healthcare expenditure, the future scenario may change.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Spain - Category Analysis

TRENDS

  • The Spanish government decided to allow sales of emergency contraception on an OTC basis in 2009, and the measure was actually implemented in 2010. There are 17 different regions which are responsible for implementing the new law, with Cataluña being the first region actually to see over-the-counter sales of these products. The other regions did not sell such products until 2010, and there are still some pharmacies reluctant to sell the products for moral reasons.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2009-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2009-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Spain - Category Analysis

HEADLINES

TRENDS

  • Like other OTC categories, eye care sales were affected by the poor economy and the high unemployment rate, resulting in sales of eye care products dropping, with more consumers going to the doctor to obtain a reimbursed product or just being more careful with how they spend their money. As a consequence, sales of eye care products declined by over 1% in 2010. This is in contrast to earlier years of the review period, which saw healthy growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Spanish eye care market continues to be highly concentrated, with almost 60% of sales in the hands of the four leading companies: McNeil Iberica, Allergan, Alcon Cusi and Reckitt Benckiser.

PROSPECTS

  • Eye care sales are predicted to decline by almost 4% in constant value terms over the forecast period, marking a slight deterioration on the review period performance. The slow recovery of the Spanish economy will hamper sales of eye care products over the 2010-2015 period. However, two factors will help to sustain sales: increasing exposure to unhealthy environments and the ageing of the Spanish population.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Spain - Category Analysis

HEADLINES

TRENDS

  • Poor economic conditions have negatively influenced the performance of herbal/traditional products, with sales dropping marginally in 2010, following a slight rise in 2009. There is a growing trend amongst Spanish consumers, especially gynaecologists and paediatricians, to recommend consumption of herbal/traditional products, but sales have suffered from the fact that Spanish consumers are cutting down on expenditure and shifting away from consumption of herbal medicines, as such products are not reimbursed.

COMPETITIVE LANDSCAPE

  • Cadbury led sales of herbal traditional products in 2010 due to its strong positioning within medicated confectionery. The company is present in the Spanish market through its brands Halls and Respiral. The company maintained its leading position over the review period, although its share has gradually declined.

PROSPECTS

  • Sales of herbal/traditional products are predicted to decline by 3% in constant value terms between 2010 and 2015. The category’s sales will be limited by the Spanish economic recovery, not by the fact the herbal/traditional products have a poor image. However, Spaniards will tend to go to the doctor to get a prescription for the medicine needed instead of getting a full priced herbal medicine.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Spain - Category Analysis

HEADLINES

TRENDS

  • Like the rest of the Spanish OTC market, sales of medicated skin care have been negatively influenced by the poor economic environment. However, the fact that in 2008 the Spanish government decide to delist vaginal antifungals, previously only available on prescription, has clearly benefited the overall performance of the category. Sales of medicated skin care grew by almost 3% in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Fragmentation continues to characterise the Spanish medicated skin care category, with over 30 companies active.

PROSPECTS

  • Although the Spanish economy is expected to record a positive albeit modest growth rate in 2011 – over 1% according to the Spanish government – it will not be until this growth reaches 3% that the Spanish economy will be able to create sustainable employment. Moreover, in 2011 and 2012, the Spanish government will need to increase taxes in order to contain the public deficit. As a consequence, disposable incomes will still suffer, damaging the performance of medicated skin care products. Sales of medicated skin care products are predicted to drop by almost 3% over the forecast period.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Spain - Category Analysis

HEADLINES

TRENDS

  • In October 2010, a new and more comprehensive ban on smoking was passed by the Spanish government. With this new ban on smoking, no smoking will be allowed in any public places, or any place where children could be exposed to tobacco, such as parks or recreation areas. The law will not come into force until 2 January 2011, however, some Spanish regions, such as the Basque Country have already begun to apply similar – in this case more restrictive – laws. In the case of the Basque Country, smoking will not be allowed even in a citizen’s own car if a minor is present.

SWITCHES

COMPETITIVE LANDSCAPE

  • The importance of OTC references within the Spanish NRT smoking cessation aids category is limited. In Spain, Rx references are more popular than their OTC counterparts. Zyntabac, from GlaxoSmithKline is the leading prescription product, followed by Pfizer’s Champix, also a prescription-only product. However, the fact that these two references are not reimbursed and are expensive is benefiting the performance of OTC products.

PROSPECTS

  • The tougher smoking ban coming into force in 2011 should help support sales of NRT cessation aids, which are expected to grow by 5% in constant value terms over the forecast period. The latest surveys indicate that the 2006 Ley Antitabaco (anti-tobacco law) failed to achieve its goal of reducing the number of Spanish smokers by 10% in 2007, and the new tougher measures will pursue more ambitious figures.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Spain - Category Analysis

HEADLINES

TRENDS

  • Value sales of sports nutrition increased marginally in 2010, following a decline in the previous year. As in the rest of consumer health, the poor economic environment, with a high level of unemployment, has resulted in Spanish consumers cutting superfluous expenditure, which has hampered the performance of the category. However, sales have been maintained by the existence of private label lines, which offer good value for money.

COMPETITIVE LANDSCAPE

  • Nutrition & Santé, with its Isostar range, ranked first in sports nutrition in 2010. The company recorded the best performance in 2010, with its share growing by almost one percentage point. In 2010, the company benefited from the shift of consumers from purchasing in gyms to the grocery channel, where the company leads sales. The company did not launch any new products in 2010, as the crisis is not consider the best period for launching new lines.

PROSPECTS

  • Sales of sports nutrition are set to grow by almost 2% in constant value terms over the forecast period. The category is set to continue on its growth path as the economy slowly recovers. However, the fact that the Spanish government will need to adopt policies to constrain the budget deficit will result in an increase in income tax and hence a decline in average disposable income. As a consequence, Spaniards will shift their consumption habits, purchasing sports nutrition product through the grocery channel in order to look for the best money for value products.

CATEGORY DATA

  • Summary 29 Sports Nutrition: Brand Ranking By Format 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Spain - Category Analysis

HEADLINES

TRENDS

  • The lack of a tradition of vitamins and dietary supplements intake amongst Spaniards continues to hamper category sales. According to industry sources, Spaniards do not feel they have the need to consume vitamins and dietary supplements, and this is the main reason for the lack of popularity of these products in Spain compared to other countries, which is reflected in low per capita consumption. Industry sources point out that only 10% of Spaniards consume vitamins or dietary supplements on a regular basis, and that doctors’ recommendations remain one of the main reasons to consume them.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The Spanish vitamins and dietary supplements category is highly fragmented, with more than 40% of total sales in the hands of small regional companies, which in most of the cases produce a limited product portfolio.

PROSPECTS

  • The recovery of the Spanish economy is likely to set the pace at which vitamins and dietary supplements grow over the forecast period. The fact that the average unit price of this category is high and the unemployment rate in Spain will be close to 21% will negatively affect its performance, with sales predicted to decline by over 6% over the 2010-2015 period.

CATEGORY DATA

  • Summary 30 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Spain - Category Analysis

HEADLINES

TRENDS

  • Weight management proved to be the most dynamic category within consumer health in 2010, in spite of the poor economy. Its strong growth in 2010, which was a significantly better performance than in the previous year, was linked to the launch in 2009 of Alli. According to industry sources, the performance of Alli has been extraordinary successful, mainly due to the good results of the product. It is also worth pointing out that Spaniards prefer an easy way to lose weight rather than a proper diet and engaging in sporting activity, and Alli, although recommended to be taken as part of weight-control, diet can also be consumed without one.

COMPETITIVE LANDSCAPE

  • In 2009, Alli, by GlaxoSmithKline, was launched on the Spanish market as the only product available in OTC obesity. In 2010, its success was such that GSK in now the third most important company in the Spanish weight management category, with a share of 17%.

PROSPECTS

  • Sales of weight management are set to record a strong performance over the forecast period, with sales growing by 28% in constant value terms. The importance of self-image will remain an important driver of sales of weight management products.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Spain - Category Analysis

HEADLINES

TRENDS

  • Spain’s deep economic crisis was the main factor shaping sales of wound care in 2010. The drop in the average disposable income has resulted in Spaniards looking for ways to save money. One means is shifting from branded products to private label ones, which offer a better value for money option. Sales of wound care dropped by over 1% in current value terms in 2010

COMPETITIVE LANDSCAPE

  • Private label recorded the best performance in 2010, with its share growing by almost one percentage point. The poor economic performance has resulted in Spaniards switching from their traditional brands to private label references, which offer good value for money.

PROSPECTS

  • Much in line with the rest of the Spanish consumer health market, the slow recovery of the Spanish economy will shapes sales of wound care products in the 2010-2015 period. Sales of wound care are predicted to decline by 7% in constant value terms over the period.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Guarana
            • Isoflavones
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Country Report

Future Demographic